Proactive Investors - Run By Investors For Investors

Rhinomed sits atop Friday’s most traded

Rhinomed sits atop Friday’s most traded

Friday’s leading volume stocks on the ASX.

NameCodeLastChangeVolume
Rhinomed ASX:RNO $0.052 92.6% 201,094,982
Collaborate Corp ASX:CL8 $0.038 -5% 27,035,631
Resmed Inc ASX:RMD $6.99 3.9% 26,895,241
Lynas Corporation ASX:LYC $0.044 -8.3% 22,371,166
Telstra Corporation ASX:TLS $6.20 0.8% 19,926,793
Eden Energy ASX:EDE $0.014 16.7% 19,924,909
Metcash Limited ASX:MTS $1.44 12.1% 18,719,733
Activistic Limited ASX:ACU $0.18 0% 17,162,582
Environmental Clean Technologies ASX:ESI $0.015 0% 16,759,616
FAR Limited ASX:FAR $0.088 -6.4% 16,006,613

 

Proactive Investors Australia is the market leader in producing news, articles and research reports on ASX emerging companies with distribution in Australia, UK, North America and Hong Kong / China.

View full RNO profile View Profile

Rhinomed Ltd Timeline

Newswire
March 13 2017

Related Articles

picture of a knee
May 21 2019
We take a closer look at Collagen Solutions, which received third-party validation of its business model in the form of outside investment from a blue-chip US agriculture company
1550850611_CancerHeadline.jpg
February 23 2019
Broker Hybridan reckons Sareum is “arguably a bargain target for the relatively large group of biotech and pharma companies interested in TYK2 and the wider JAK inhibitor space”
scientists in a lab
January 31 2019
The technology first drew the attention of ChemioCare CEO Pedro Lichtinger years ago while he oversaw Pfizer's global primary care business

© Proactive Investors 2019

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use